Cerus lands additional $15m in government funding

This article was originally published here

Cerus (NSDQ:CERS) landed a $15 million amendment to its contract with the U.S. Dept. of Health & Human Services’ Biomedical Advanced Research and Development Authority, bringing the total potential value of its deal to $201 million.

The expanded agreement is designed to support additional clinical trials of the company’s Intercept blood transfusion technology.

Get the full story at our sister site, Drug Delivery Business News.

The post Cerus lands additional $15m in government funding appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply